US Patent Issued to SHENZHEN FORWARD PHARMACEUTICALS on March 25 for "Azaaromatic amide derivatives for the treatment of cancer" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,344, issued on March 25, was assigned to SHENZHEN FORWARD PHARMACEUTICALS Co. LTD. (Guangdong, China).

"Azaaromatic amide derivatives for the treatment of cancer" was invented by Chenggang Zhu (Guangdong, China), Xuan Yang (Guangdong, China), Chaochun Zhang (Guangdong, China), John J. Talley (Guangdong, China), Chaole Chen (Guangdong, China), Liming Bao (Guangdong, China) and Liangliang Xu (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to azaaromatic amide derivatives for the treatment of cancer. Specifically, the present application relates to a preparation method and use of azaaromatic amide deriv...